Epsilon HealthcareASX:EPN ROC (Joel Greenblatt) % is 22.19% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 978 Drug Manufacturers companies, Epsilon Healthcare ranks worse than 79.04% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Epsilon Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 22.19%.
The historical rank and industry rank for Epsilon Healthcare's ROC (Joel Greenblatt) % or its related term are showing as below:
ASX:EPN'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -117.74 Med: -46.53 Max: -14.28
Current: -16.48
During the past 9 years, Epsilon Healthcare's highest ROC (Joel Greenblatt) % was -14.28%. The lowest was -117.74%. And the median was -46.53%.
ASX:EPN's ROC (Joel Greenblatt) % is ranked worse than 79.04% of 978
companies
in the Drug Manufacturers industry
Industry Median: 11.45
vs ASX:EPN: -16.48
Epsilon Healthcare's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 15.00% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Epsilon Healthcare ROC (Joel Greenblatt) % Related Terms
Epsilon Healthcare ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Epsilon Healthcare's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:EPN vs ZTS, UTHR: ROC (Joel Greenblatt) % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epsilon Healthcare ROC (Joel Greenblatt) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Epsilon Healthcare's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 22.19% mean?
Epsilon Healthcare (ASX:EPN) has a ROC (Joel Greenblatt) % of 22.19% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Epsilon Healthcare and its competitors. According to the industry distribution chart, Epsilon Healthcare ranks #773 out of 978 companies in the Drug Manufacturers industry, placing it in the top 79%.
Is Epsilon Healthcare's ROC (Joel Greenblatt) % too high?
Epsilon Healthcare's current ROC (Joel Greenblatt) % is 22.19%. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.45. Epsilon Healthcare's value of 22.19% is 93.8% above this industry median. Based on the distribution chart, Epsilon Healthcare ranks #773 out of 978 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Epsilon Healthcare's ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Epsilon Healthcare ranks #773 out of 978 companies for ROC (Joel Greenblatt) %. This places Epsilon Healthcare in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 11.45. Epsilon Healthcare's value of 22.19% is 93.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.45, based on 978 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Epsilon Healthcare's current ROC (Joel Greenblatt) % of 22.19% is 93.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Epsilon Healthcare and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epsilon Healthcare's current ROC (Joel Greenblatt) % is 22.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epsilon Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Epsilon Healthcare (ASX:EPN) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.02 — trading 26.7% below its estimated fair value. The current ROC (Joel Greenblatt) % is 22.19% and 93.8% above the Drug Manufacturers industry median of 11.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Epsilon Healthcare (ASX:EPN), the current ROC (Joel Greenblatt) % is 22.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Epsilon Healthcare Ltd is an Australian based, globally active healthcare organisation. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacturing operation & pharmacy services. The company offers end-to-end solutions across the healthcare spectrum: from product development and manufacturing to patient care. The company's three (3) main operating segments are: a. Contract Development and Manufacturing activities, b. Telehealth medical practice services; and c. Pharmacy services. The majority of revenue is derived from the Contract Development and Manufacturing activities segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EPN has been successfully added to your 